DIN 02296314 — ELAPRASE 2 MG
ELAPRASE is a solution of Idursulfase marketed by TAKEDA CANADA INC. The full Idursulfase monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02296314
- Brand name
- ELAPRASE
- Active ingredient
- Idursulfase
- Strength
- 2 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- TAKEDA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Enzyme replacement therapy (recombinant iduronate-2-sulfatase)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.